Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Game On, page-541

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 541 Last

Share
Profile

Follow
Dundasbro

10 Posts.

21/07/17

14:42

Post #: 26007576
Share

Originally posted by Bocholt ↑

extract of an article in todays Australian
-------------
Just over a week ago, The Medical Journal of Australia published a study led by Chris Del Mar from Bond University showing GPs are prescribing antibiotics for acute respiratory infections at rates four to nine times higher than recommended by national guidelines.
Even when there are guidelines, there is overprescribing. Turnidge believes national efforts to reduce the prescribing rate, and educate consumers on the appropriate use of antibiotics, need to be stepped up to have an impact.

“ I think more needs to be done, we’ve been doing much the same for 15 years with NPS MedicineWise (which promotes evidence-based practices),” Turnidge says. “Turning around 30 million scripts to 24 million Australians is going to be like turning around the Titanic — we’re going to need a lot of ropes and pulleys.”

Encouraging doctors and hospitals to prescribe fewer antibiotics, or prescribe only when clinically indicated, is one side of the response. Consumers, too, need to realise antibiotics are not a cure-all and, when they are prescribed, need to be taken responsibly. Most people know what it is like to have a cold, feel miserable and wonder if antibiotics might help.
----------

we are way beyond ropes and pulley's....Imagine 30 million scripts that may not need to happen...all because of "30 million tests using ResappDx" either we will be rich at $10 a test, or the company will be bought by the makers of antibiotics.

Just thought Id brighten up a dull day

Expand

Just a quick (ignorant) question - it would be $10 per purchase of the app, is that right? Rather than $10 per test?

RAP Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN